Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward
Abstract The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local populati...
Main Authors: | Xue-Lian Zhao, Shang-Ying Hu, Jia-Wei Hu, Hong-Hao Wang, Tian-Meng Wen, Yu-Shu Feng, You-Lin Qiao, Fang-Hui Zhao, Yong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Infectious Diseases of Poverty |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40249-023-01136-6 |
Similar Items
-
Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
by: Ji Jia, et al.
Published: (2012-06-01) -
HUMAN PAPILLOMAVIRUS INFECTION AND HEAD AND NECK CANCER PROGRESSION
by: V. A. Bychkov, et al.
Published: (2014-07-01) -
Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
by: Rufei Duan, et al.
Published: (2020-01-01) -
The papillomaviruses /
by: Garcea, Robert L., et al.
Published: (2007) -
Prevalence and genotype distribution of human papillomavirus: implications for cancer screening and vaccination in Henan province, China
by: Jun-Wei Zhao, et al.
Published: (2016-04-01)